Pamapimod, a Novel p38 Mitogen-Activated Protein Kinase Inhibitor: Preclinical Analysis of Efficacy and Selectivity

Hill, R. J.; Dabbagh, K.; Phippard, D.; Li, C.; Suttmann, R. T.; Welch, M.; Papp, E.; Song, K. W.; Chang, K.-c.; Leaffer, D.; Kim, Y.-N.; Roberts, R. T.; Zabka, T. S.; Aud, D.; Porto, J. D.; Manning, A. M.; Peng, S. L.; Goldstein, D. M.; Wong, B. R.

期刊名称Journal of Pharmacology and Experimental Therapeutics
作者Hill, R. J.; Dabbagh, K.; Phippard, D.; Li, C.; Suttmann, R. T.; Welch, M.; Papp, E.; Song, K. W.; Chang, K.-c.; Leaffer, D.; Kim, Y.-N.; Roberts, R. T.; Zabka, T. S.; Aud, D.; Porto, J. D.; Manning, A. M.; Peng, S. L.; Goldstein, D. M.; Wong, B. R.
卷第327卷
期第3期
印刷ISSN0022-3565
电子ISSN1521-0103
文件大小474.11KB
发表时间2008-09-05
DOI10.1124/jpet.108.139006
页码610-619

发现好书期刊，享受阅读乐趣

Pamapimod, a Novel p38 Mitogen-Activated Protein Kinase Inhibitor: Preclinical Analysis of Efficacy and Selectivity